ArticleJournal of the Endocrine Society2026

Cardiometabolic and atherosclerotic cardiovascular disease outcomes associated with tirzepatide: insights from a 1-year multicenter observational study.

Rene de J Rivera Gutierrez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.